Compare PTGX & CSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | CSW |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | US | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.8B |
| IPO Year | 2016 | N/A |
| Metric | PTGX | CSW |
|---|---|---|
| Price | $82.25 | $306.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 5 |
| Target Price | $99.20 | ★ $321.40 |
| AVG Volume (30 Days) | ★ 600.9K | 178.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.36% |
| EPS Growth | ★ 404.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.19 |
| Revenue Next Year | $501.99 | $16.82 |
| P/E Ratio | ★ N/A | $40.25 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.70 | $230.45 |
| 52 Week High | $96.54 | $337.02 |
| Indicator | PTGX | CSW |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 52.27 |
| Support Level | $80.40 | $282.79 |
| Resistance Level | $83.40 | $311.38 |
| Average True Range (ATR) | 3.21 | 13.27 |
| MACD | 0.04 | 1.72 |
| Stochastic Oscillator | 45.85 | 63.88 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.